(Q43059658)

13 November 2017

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial (English)

1 reference

13 November 2017

0 references

1 reference

cognitive dysfunction

1 reference

J F Lovera

1

1 reference

13 November 2017

E Frohman

2

1 reference

13 November 2017

T R Brown

3

1 reference

13 November 2017

D Bandari

4

1 reference

13 November 2017

L Nguyen

5

1 reference

13 November 2017

V Yadav

6

1 reference

13 November 2017

O Stuve

7

1 reference

13 November 2017

J Karman

8

1 reference

13 November 2017

K Bogardus

9

1 reference

13 November 2017

G Heimburger

10

1 reference

13 November 2017

L Cua

11

1 reference

13 November 2017

G Remingon

12

1 reference

13 November 2017

J Fowler

13

1 reference

13 November 2017

T Monahan

14

1 reference

13 November 2017

S Kilcup

15

1 reference

13 November 2017

Y Courtney

16

1 reference

13 November 2017

J McAleenan

17

1 reference

13 November 2017

K Butler

18

1 reference

13 November 2017

K Wild

19

1 reference

13 November 2017

R Whitham

20

1 reference

13 November 2017

D Bourdette

21

1 reference

13 November 2017

18 May 2010

1 reference

Multiple Sclerosis Journal

13 November 2017

1 reference

13 November 2017

16

1 reference

13 November 2017

6

1 reference

13 November 2017

715-723

1 reference

Neuropsychology of multiple sclerosis: a critical review

13 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Effects of donepezil on memory and cognition in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Memantine in moderate-to-severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Minimal neuropsychological assessment of MS patients: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Predicting neuropsychological abnormalities in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

Memantine induces reversible neurologic impairment in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510367662

21 January 2018

Identifiers

DOI

10.1177/1352458510367662

1 reference

13 November 2017

1 reference